At 24 weeks, weight reductions ranged from 7.2% with the 1 mg dose to 17.5% with the 12 mg dose, all significantly superior to placebo
When in doubt about temperature exposure, contact your pharmacy about whether the medication is still viable
Liraglutide was finally approved in 2010 for the treatment of patients with type 2 diabetes unable to regulate their blood sugar with other insulin medications (Gilbert, Rosenthal, Jan 2024)
All sales on the Website are final and we do not accept any returns outside of any stated terms outlined in the Shipping & Returns policy
The goal is smoother drug levels (lower peaks, higher troughs), which can reduce the nausea spike that hits 1-2 days after a full weekly injection
Similarly, switching from Lantus to Toujeo is a within-class insulin change, not a transition between drug categories